Market Overview

Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

Share:
Related CRL
A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Yellen Speech
Earnings Scheduled For February 14, 2017
HealthInvest Partners AB Buys Aetna, Osiris Therapeutics, Achillion Pharmaceuticals, Sells ... (GuruFocus)
Related SHP
ShangPharma Announces Completion of Merger
ShangPharma Shareholders Approve Merger Agreement

Below are the top biotechnology stocks on the NYSE in terms of return on assets.

The trailing-twelve-month return on assets at Charles River Laboratories International (NYSE: CRL) is 7.63%. Charles River Laboratories' operating margin for the same period is 16.89%.

The trailing-twelve-month return on assets at Emergent BioSolutions (NYSE: EBS) is 7.42%. Emergent BioSolutions' revenue for the same period is $295.23 million.

The trailing-twelve-month return on assets at Cambrex (NYSE: CBM) is 6.20%. Cambrex had $33.52 million in total cash for the recent quarter.

The trailing-twelve-month return on assets at ShangPharma (NYSE: SHP) is 2.26%. ShangPharma's PEG ratio is 1.20.

Posted-In: Biotechnology Industry Highest ROA NYSETrading Ideas

 

Related Articles (CBM + CRL)

View Comments and Join the Discussion!